AtriCure, Inc. (ATRC) Misses Q1 EPS by 9c

AtriCure, Inc. (NASDAQ: ATRC) reported Q1 EPS of ($0.31), $0.09 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $24.8 million versus the consensus estimate of $23.36 million.

AtriCure, Inc. sees FY2014 revenue of $101-104 million, versus prior guidance of $100-103 million and the consensus of $101.91 million.

For earnings history and earnings-related data on AtriCure, Inc. (ATRC) click here.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• Nortech Systems, Inc. (NSYS) Tops Q2 EPS by 11c
• ArriVent BioPharma, Inc. (AVBP) Misses Q2 EPS by 13c